Semaglutide (Wegovy) and liraglutide (Saxenda) work by mimicking the glucagon-like peptide-1 hormone, which regulates appetite and food intake
REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis
Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ
The company presents this as context drawn from clinical literature, not a guarantee of individual outcomes
All statistics and clinical interpretations are sourced from published Phase 2 and Phase 3 trial results as of October 2025
Combination therapy has several potential advantages, including (1) increased durability of the glycaemic effect [225,226,227], addressing therapeutic inertia, (2) simultaneous targeting of the multiple pathophysiological processes characterised by type 2 diabetes, (3) impacts on medication burden, medication-taking behaviour and treatment persistence and (4) complementary clinical benefits (e.g